South African e-health startup Envisionit Deep AI has announced a collaboration agreement with Bayer in the radiology domain to explore potential future use cases for parts of its portfolio, including Bayer’s AI innovation Platform. This platform is a cloud-based, end-to-end software development environment designed for imaging-based AI applications.
Envisionit Deep AI was founded in 2019 by Dr. Jaishree Naidoo, Andrei Migatchev, and Terence Naidu. The company focuses on developing innovative medical solutions that leverage the power of artificial intelligence to revolutionize the way healthcare professionals diagnose and treat patients. One of their key technologies, RADIFY AI, enhances the speed, accuracy, quality, and affordability of medical imaging diagnoses. This technology is particularly crucial for the early detection and treatment of various diseases, including tuberculosis, coronavirus pneumonia, and breast cancer.
In February 2023, Envisionit Deep AI successfully raised $1.65 million in funding. Building on this momentum, the company has now partnered with Bayer to further advance AI-driven medical imaging diagnostics. The collaboration aims to enhance the compliance, accuracy, and reliability of AI technologies in clinical environments.
Dr. Jaishree Naidoo, co-founder of Envisionit Deep AI, expressed enthusiasm about the partnership, stating, “The agreement to explore with Bayer in radiology future use cases for our tools is an exciting one for us as we are taking a significant step toward advancing AI reliability and compliance in medical diagnostics.”
She further emphasized the importance of the collaboration, noting, “This collaboration underscores our shared dedication to addressing critical challenges in AI implementation, delivering solutions that not only improve patient outcomes but also empower radiologists with trustworthy, cutting-edge technology.”
Through this partnership, Envisionit Deep AI and Bayer aim to contribute significantly to the field of medical imaging diagnostics, ensuring that AI technologies are both reliable and compliant with clinical standards. This joint effort is expected to lead to advancements that will benefit patients and healthcare professionals alike, fostering a future where AI plays a pivotal role in medical diagnostics.
